Article Abstract

Gut microbiome-immune crosstalk affects progression of cancer

Authors: Herbert Tilg, Andreas Schmiderer, Angela Djanani


The intestinal microbiota is increasingly recognized as a major modulator of health and disease (1). The dramatic explosion of genetic tools and metagenomic techniques in the last decade allowed to characterize the composition of the microbiome from several areas of the body. In addition, this knowledge increasingly enables scientists to link composition and changes with human health and more importantly with various disorders far beyond the gastrointestinal tract (2,3).